Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate versus propofol for ERCP under monitored anesthesia care
ChiCTR2100044502Phase 4Completed
- Sponsor
- Tongji Hospital
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Pancreatic duct stricture, Pancreatic duct stone, biliary stricture and 6 more comparing Propofol group with Remimazolam tosilate group (2 arms). Primary endpoints: Bispectral index, Ramsay sedation scale score and 8 more. Started Jun 2021; status: completed.
02
Drugs
remimazolampropofol
03
Conditions
Pancreatic duct stricturePancreatic duct stonebiliary stricturecholedocholithiasisobstructive jaundice
Beyond the preview
Go deeper on ChiCTR2100044502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044502.